Cargando…
The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and “Nose-to-Brain”
Sino-nasal disease is appropriately treated with topical treatment, where the nasal mucosa acts as a barrier to systemic absorption. Non-invasive nasal delivery of drugs has produced some small molecule products with good bioavailability. With the recent COVID pandemic and the need for nasal mucosal...
Autor principal: | Shrewsbury, Stephen B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303426/ https://www.ncbi.nlm.nih.gov/pubmed/37376168 http://dx.doi.org/10.3390/pharmaceutics15061720 |
Ejemplares similares
-
The Pharmacokinetics of Drugs Delivered to the Upper Nasal Space
por: Shrewsbury, Stephen B.
Publicado: (2023) -
Nasal Delivery of Acute Medications for Migraine: The Upper Versus Lower Nasal Space
por: Martin, Vincent, et al.
Publicado: (2021) -
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action
por: Cooper, Wade, et al.
Publicado: (2022) -
Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols
por: Alabsi, Wafaa, et al.
Publicado: (2022) -
In Vitro Evaluation of Nasal Aerosol Depositions: An Insight for Direct Nose to Brain Drug Delivery
por: Maaz, Aida, et al.
Publicado: (2021)